The myocardial and neuronal infectivity of SARS-CoV-2 and detrimental outcomes.

TitleThe myocardial and neuronal infectivity of SARS-CoV-2 and detrimental outcomes.
Publication TypeJournal Article
Year of Publication2021
AuthorsHerbert, E, Fournier, D, Al-Shaqha, WMohammed, Chahine, M
JournalCan J Physiol Pharmacol
Volume99
Issue11
Pagination1128-1136
Date Published2021 Nov
ISSN1205-7541
KeywordsHeart, Humans, Middle Aged, Neurons, SARS-CoV-2
Abstract

The epidemiological outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alias COVID-19, began in Wuhan, Hubei, China, in late December and eventually turned into a pandemic that has led to over 3.71 million deaths and over 173 million infected cases worldwide. In addition to respiratory manifestations, COVID-19 patients with neurological and myocardial dysfunctions exhibit a higher risk of in-hospital mortality. The immune function tends to be affected by cardiovascular risk factors and is thus indirectly related to the prognosis of COVID-19 patients. Many neurological symptoms and manifestations have been reported in COVID-19 patients; however, detailed descriptions on the prevalence and characteristic features of these symptoms are restricted due to insufficient data. It is thus advisable for clinicians to be vigilant for both cardiovascular and neurological manifestations to detect them at an early stage to avoid inappropriate management of COVID-19 and to address the manifestations adequately. Patients with severe COVID-19 are notably more susceptible to developing cardiovascular and neurological complications than non-severe COVID-19 patients. This review focuses on the consequential outcomes of COVID-19 on cardiovascular and neuronal functions, including other influencing factors.

DOI10.1139/cjpp-2021-0390
Alternate JournalCan J Physiol Pharmacol
PubMed ID34546143